<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="158188">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02062593</url>
  </required_header>
  <id_info>
    <org_study_id>ORBITA-1</org_study_id>
    <nct_id>NCT02062593</nct_id>
  </id_info>
  <brief_title>Comparison of Coronary Angioplasty and Optimum Medical Therapy Versus Optimal Medical Therapy in the Stable Angina</brief_title>
  <acronym>ORBITA</acronym>
  <official_title>Defining a Gold Standard for Ischaemia: Effects of Interventional Revascularisation Versus Optimum Medical Therapy on Exercise Capacity in Patients With Stable Coronary Artery Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Imperial College London</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Volcano Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Imperial College London</source>
  <oversight_info>
    <authority>United Kingdom: Research Ethics Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study the investigators will use careful scientific blinding of patient and their
      subsequent healthcare staff so that the investigators can determine exactly how much
      difference coronary angioplasty makes to symptoms and blood supply to the heart. After the 6
      weeks blinded phase, all patients will be unblinded and the patients who had undergone sham
      procedure will be offered the active therapy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators will perform a multi-centre prospective randomised double-blinded
      comparison of the treatment of stable angina with percutaneous coronary intervention (PCI)
      and optimal medical therapy (OMT) versus a sham procedure and OMT. Three hundred patients
      with stable angina and one or more angiographically significant coronary stenosis of 70% or
      more in a single vessel that is suitable for angioplasty will be recruited. Baseline
      investigation of functional capacity and myocardial ischaemic burden will be performed. This
      will be followed by a coronary angiogram and invasive physiological  investigation followed
      by randomisation to PCI or a sham procedure. Follow-up investigation of functional capacity
      and myocardial ischaemic burden at 6 weeks will then be performed.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Exercise time on treadmill</measure>
    <time_frame>6 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Stable Angina</condition>
  <arm_group>
    <arm_group_label>Coronary angioplasty</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Percutaneous coronary intervention and optimal medical therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Optimal medical therapy</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo percutaneous coronary intervention and optimal medical therapy with risk factor modification and anti-anginal therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Coronary angioplasty</intervention_name>
    <description>Percutaneous coronary intervention with drug-eluting stents and modern techniques</description>
    <arm_group_label>Coronary angioplasty</arm_group_label>
    <arm_group_label>Optimal medical therapy</arm_group_label>
    <other_name>Percutaneous coronary intervention</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Stable angina and at least 1 lesion with angiographic stenosis ≥70% in a single
             vessel suitable for stent implantation

        Exclusion Criteria:

          -  Acute coronary syndrome

          -  Previous coronary artery bypass graft surgery

          -  Left main stem disease

          -  Contraindications to PCI or drug-eluting stent (DES) implantation

          -  Heavily calcified or tortuous vessels

          -  Chronic total occlusion in target vessel

          -  Life expectancy &lt;2yr

          -  Pregnancy

          -  Age &lt;18yr or &gt;85yr

          -  Angiographic stenosis ≥ 50% in non-target vessel

          -  Inability to consent
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Justin E Davies, MRCP, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Imperial College London</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Darrel P Francis, MRCP, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Imperial College London</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rasha K Al-Lamee, MRCP</last_name>
    <role>Study Director</role>
    <affiliation>Imperial College London</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rasha Al-Lamee</last_name>
    <email>r.al-lamee13@imperial.ac.uk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Basildon and Thurrock University Hospitals NHS Trust</name>
      <address>
        <city>Basildon</city>
        <zip>SS16 5NL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kare Tang, FRCP</last_name>
      <email>kare.tang@btuh.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Kare Tang, FRCP</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>John Davies, MRCP PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Devon &amp; Exeter Foundation Trust</name>
      <address>
        <city>Exeter</city>
        <zip>EX2 5DW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Andrew Sharp, MRCP MD</last_name>
      <email>andrewsharp@doctors.org.uk</email>
    </contact>
    <investigator>
      <last_name>Andrew Sharp, MRCP MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Imperial College Healthcare NHS Trust</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rasha Al-Lamee, MRCP</last_name>
      <email>r.al-lamee13@imperial.ac.uk</email>
    </contact>
    <investigator>
      <last_name>Justin E Davies, MRCP PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <link>
    <url>http://www.tctmd.com/show.aspx?id=121398</url>
    <description>Transcatheter Cardiovascular Therapeutics 2013 Study outline presentation</description>
  </link>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>March 25, 2014</lastchanged_date>
  <firstreceived_date>January 31, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Stable angina</keyword>
  <keyword>Percutaneous coronary intervention</keyword>
  <keyword>Optimal medical therapy</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>No</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Angina Pectoris</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
